Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals makes medicines using a technology called RNA interference, which works by silencing disease-causing genes. The company has several drugs already approved and sold, including ONPATTRO for a rare heart condition, AMVUTTRA for another inherited disease, and Leqvio to help lower cholesterol. Many more medicines are in development for diseases like high blood pressure, diabetes, liver disease, and Alzheimer's, though these are still being tested and not yet available to patients.